Hudson, C <br/><br/>
Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia.  [electronic resource] 

 -  Biological psychiatry  Aug 1999 
 - 401-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-3223 
<br/><br/><label>Standard No.: </label>10.1016/s0006-3223(99)00010-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--therapeutic use<br/>Arachidonic Acid--metabolism<br/>Calcium--metabolism<br/>Calmodulin--metabolism<br/>Chlorpromazine--therapeutic use<br/>Enzyme Activation--physiology<br/>Female<br/>Humans<br/>Male<br/>Niacin--metabolism<br/>Phospholipases A--metabolism<br/>Phospholipases A2<br/>Schizophrenia--drug therapy<br/>Second Messenger Systems--physiology